SOPHiA GENETICS (SOPH) Other financing activities (2021 - 2025)

SOPHiA GENETICS's (SOPH) quarterly Other financing activities came in at -$990000.0 in Q1 2025, down 33.24% year-on-year from -$1.5 million in Q1 2024, and down 33.24% quarter-over-quarter from -$743000.0 in Q1 2024.

SOPHiA GENETICS (SOPH) Other financing activities (2021 - 2025) Analysis & Trends

SOPHiA GENETICS has disclosed Other financing activities across 5 years of filings, most recently posting -$990000.0 for Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn
10 SOPHiA GENETICS 26.19 Mn -44.10 Mn 14.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2025 -990,000.00
Mar 31, 2025 -990,000.00
Mar 31, 2024 -743,000.00
Mar 31, 2024 -743,000.00
Mar 31, 2023 -935,000.00
Mar 31, 2023 -935,000.00
Sep 30, 2022 -809,000.00
Sep 30, 2022 -809,000.00
Jun 30, 2022 232,000.00
Jun 30, 2022 232,000.00
Mar 31, 2022 -411,000.00
Mar 31, 2022 -411,000.00
Sep 30, 2021 237.69 Mn
Sep 30, 2021 237.69 Mn
Jun 30, 2021 1.83 Mn
Jun 30, 2021 1.83 Mn
Mar 31, 2021 -1.30 Mn
Mar 31, 2021 -1.30 Mn